Ensayos clínicos

Inclusion Criteria:

• Adults ≥ 18 years old.
• Ability to give informed consent.
• Diagnosis of ulcerative colitis.
• Mild-to-moderate UC disease activity defined by a May Full Score of ≥ 4 with endoscopic score of ≥ 1.
• On a baseline diet characterized by:
  • Fiber intake of < 20g/day;
  • > 18% of daily calories from protein,

 Exclusion Criteria:

• Prior history of gastrointestinal surgeries (except appendectomy and cholecystectomy).
• Use of NSAIDs or aspirin and unable or unwilling to stop taking two weeks prior to permeability test and for the duration of the study.
• Use of osmotic laxatives and unable or unwilling to stop taking one week prior to permeability test and for the duration of the study.
• Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous 2 weeks and for the duration of the study.
• Multiple dietary restrictions or unable/unwilling to alter dietary protein or dietary fiber.
• Unwilling to stop ingestion of alcohol and artificial sweeteners such as Splenda™ (sucralose), Nutrasweet™ (aspartame), sorbitol, xylitol, lactulose, or mannitol 2 days before and during the permeability testing days; e.g. foods to be avoided are sugarless gums or mints and diet beverages.
• Bowel preparation for colonoscopy less than one week prior to completion of the first stool kit and permeability test and flexible sigmoidoscopy and upper endoscopy.
• Pregnancy or plan to become pregnant during the study time frame.
• Vulnerable adult.
• Known bleeding disorders or takes medications that increase risk of bleeding from mucosal biopsies.
• Use of oral antibiotic(s) within the past 4 weeks (can be enrolled after 4-week washout period).
• Use of commercial probiotic formulations and unwilling to stop for the duration of the study.
• Diagnosis of diabetes.
• Any other disease(s), condition(s) or habits(s) that would interfere with completion of study, or in the judgment of the investigator would potentially interfere with compliance to this study or would adversely affect study outcomes.

Eligibility last updated 1/6/22. Questions regarding updates should be directed to the study team contact.